Key facts
- This page summarizes M33 Growth I L.P.'s Form 4 filing for Oncology Institute, Inc. (TOI).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2025, 16:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Additional SEC filing notes
Footnote F1
On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners.
Footnote F2
These securities were held by TOI M, LLC.
Footnote F3
M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.